DOCETAXEL-GEMCITABINE AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED GASTRIC CANCER

被引：0
|
作者：
D'Alessio, Andrea [1 ]
Amato, Maria Grazia [1 ]
Resta, Davide [1 ]
Sbarufatti, Antonio
Tacchini, Laura [1 ]
Venturi, Cristina [1 ]
Visacarra, Cecilia [1 ]
机构：
[1] Med Oncoematol Policlin S Marco Zingonia BG, Bergamo, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SAFETY OF DOCETAXEL MONOTHERAPY AS SECOND-LINE TREATMENT IN ADVANCED NSCLC ELDERLY PATIENTS
    Song, X.
    Li, P.
    Zhang, G.
    Fu, P.
    Peng, A.
    Tan, M.
    Liu, Y.
    Li, M.
    Li, X.
    Wang, C.
    RESPIROLOGY, 2011, 16 : 173 - 173
  • [22] Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Saif, Muhammad Wasif
    Syrigos, Kostas
    Penney, Robin
    Kaley, Kristin
    ANTICANCER RESEARCH, 2010, 30 (07) : 2905 - 2909
  • [23] Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1178 - 1179
  • [24] Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Tschoep-Lechner, Katharina Elisabeth
    Milani, Valeria
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf-Dieter
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (01) : 8 - 16
  • [25] GEMCITABINE AND CISPLATIN COMBINED WITH REGIONAL HYPERTHERMIA AS SECOND-LINE TREATMENT IN PATIENTS WITH GEMCITABINE-REFRACTORY ADVANCED PANCREATIC CANCER
    Lechner, Katharina
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
  • [26] Docetaxel in the first- and second-line therapy of gastric cancer
    Vanhoefer, U
    ONKOLOGIE, 2000, 23 : 40 - 42
  • [27] SECOND-LINE DOCETAXEL (D) IN METASTATIC GASTRIC CANCER (MGC)
    Caparello, C.
    Lencioni, M.
    Vasile, E.
    Caponi, S.
    Santi, S.
    Fabrini, M. G.
    Ginocchi, L.
    Lucchesi, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 251 - 251
  • [28] Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed
    Schmid, KE
    Kornek, GV
    Schüll, B
    Raderer, M
    Lenauer, A
    Depisch, D
    Lang, F
    Scheithauer, W
    ONKOLOGIE, 2003, 26 (03): : 255 - 258
  • [29] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Girardi, Daniel M.
    Faria, Luiza Dib B. B.
    Teixeira, Marcela C.
    Costa, Frederico P.
    Hoff, Paulo Marcelo G.
    Fernandes, Gustavo S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (04) : 860 - 866
  • [30] Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
    Hawkes, Eliza
    Okines, Alicia F. C.
    Papamichael, Demetris
    Rao, Sheela
    Ashley, Sue
    Charalambous, Haris
    Koukouma, Alona
    Chau, Ian
    Cunningham, David
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (08) : 1146 - 1151
12345